Skip to main content

Premalignant Lesions of the Penis

  • Chapter
  • First Online:
Textbook of Penile Cancer

Abstract

Premalignant lesions present a particularly unique challenge in penile cancer. They can be difficult to distinguish from other benign dermatoses and have an uncertain natural history. A tendency for delayed presentation, with an all too common history of long-term self management, or unsuccessful treatment, often results in a relatively treatable premalignant lesion progressing to an invasive carcinoma, requiring more aggressive surgery, with poorer outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gregoire L, Cubilla AL, Reuter VE, et al. Preferential association of human papillomavirus with high-grade histologic variants of penile invasive squamous cell carcinoma. J Natl Cancer Inst. 1995;87:1705–9.

    Article  CAS  PubMed  Google Scholar 

  2. Bezerra A, Lopes A, Santiago G, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91:2315–21.

    Article  CAS  PubMed  Google Scholar 

  3. Iwasawa A, Kumamoto Y, Fujinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol. 1993;149:59–63.

    Article  CAS  PubMed  Google Scholar 

  4. Sarkar FH, Miles BJ, Plieth DH, et al. Detection of human papillomavirus in squamous neoplasm of the penis. J Urol. 1992;147:389–92.

    Article  CAS  PubMed  Google Scholar 

  5. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Heideman DA, Waterboer T, Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007;25(29):4550–6.

    Article  PubMed  Google Scholar 

  7. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20(4):449–57.

    Article  PubMed  Google Scholar 

  8. Ambrosio MR, Onorati M, Rocca BJ, et al. Vulvar cancer and HPV infection: analysis of 22 cases. Pathologica. 2008;100:405–7.

    CAS  PubMed  Google Scholar 

  9. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol. 1994;186:101–19.

    CAS  PubMed  Google Scholar 

  10. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76–9.

    Article  CAS  PubMed  Google Scholar 

  11. Dyson N, Howley PM, Münger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–7.

    Article  CAS  PubMed  Google Scholar 

  12. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342–50.

    Google Scholar 

  13. Renaud-Vilmer C, Cavelier-Balloy B, Veraola O, et al. Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma. J Am Acad Dermatol. 2009;62(2):284–90.

    Article  Google Scholar 

  14. Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85(1):19–24.

    Article  CAS  PubMed  Google Scholar 

  15. Porter WM, Francis N, Hawkins D, Dinneen M, Bunker CB. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol. 2002;147(6):1159–65.

    Article  CAS  PubMed  Google Scholar 

  16. Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EI, zur Hausen H. Human papillomavirus type-16-related DNA in genital Bowen’s disease and in bowenoid papulosis. Int J Cancer. 1983;32(5):563–5.

    Google Scholar 

  17. Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol. 2000;115(3):396–401.

    Article  CAS  PubMed  Google Scholar 

  18. Lucia MS, MiUer GJ. Histopathology of malignant lesions of the penis. Urol Clin North Am. 1992;19:227–46.

    CAS  PubMed  Google Scholar 

  19. Mikhall GR. Cancers, precancers, and pseudocancers on the male genitalia: a review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6:1027–35.

    Article  Google Scholar 

  20. Obalek S, Jablonska S, Beaudenon S, Walczak L, Orth G. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol. 1986;14(3):433–44.

    Article  CAS  PubMed  Google Scholar 

  21. von Krogh G, Horenblas SN. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol. 2000;34:201–21.

    Article  Google Scholar 

  22. Rosemberg SK. Sexually transmitted papillomaviral infection in men: an update. Dermatol Clin. 1991;9:317–31.

    CAS  PubMed  Google Scholar 

  23. Gissmann L, De Villiers EM, Zur Hausen H. Analysis of the human genital warts (condyloma acuminate) and other genital tumor for human papillomavirus type 6 DNA. Int J Cancer. 1982;29:143–6.

    Article  CAS  PubMed  Google Scholar 

  24. Wells M, Robertson S, Lewis F. Squamous carcinoma arising in giant perianal condyloma associated with human papillomavirus types 6 and 11. Histopathology. 1988;12:319–23.

    Article  CAS  PubMed  Google Scholar 

  25. Buschke A, Lowenstein L. Uber carcinomahnliche condyloma acuminate des penis. Klin Wochenschr. 1925;4:1726–8.

    Article  Google Scholar 

  26. Creasman C, Haas PA, Fox TA, Balazs M. Malignant transformation of anorectal giant condyloma acuminatum (Buschke Lowenstein tumor). Dis Colon Rectum. 1989;32:481–7.

    Article  CAS  PubMed  Google Scholar 

  27. Knobling R, Failing JF. Giant condyloma acuminatum (Buschke Lowenstein tumor) of the rectum. Am J Clin Pathol. 1967;48:389–95.

    Article  Google Scholar 

  28. Chu QD, Vereridis MP, Libbey NP, Wanebo HJ. Giant condyloma acuminatum (Buschke Lowenstein tumor) of the anorectal and perianal regions. Dis Colon Rectum. 1994;37:950–7.

    Article  CAS  PubMed  Google Scholar 

  29. Bertram P, Treutner KH, Rubben A, et al. Invasive squamous cell carcinoma in giant anorectal condyloma (Buschke Lowenstein tumor). Langenbecks Arch Chir. 1995;380:115–8.

    Article  CAS  PubMed  Google Scholar 

  30. Cubilla AL, Lloveras B, Alejo M, et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol. 2010;34(1):104–14.

    Article  PubMed  Google Scholar 

  31. Wiener JS, Effert PJ, Humphrey PA, Yu L, Liu ET, Walther PJ. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction. Int J Cancer. 1992;50(5):694–701.

    Article  CAS  PubMed  Google Scholar 

  32. Lont AP, Kroon BK, Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078–81.

    Article  CAS  PubMed  Google Scholar 

  33. Bleeker MCG, Heideman DAM, Snijders PJF, et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141–50.

    Article  CAS  PubMed  Google Scholar 

  34. Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N, Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26:730–7.

    Article  CAS  PubMed  Google Scholar 

  35. Bunker CB, Shim TN. Male genital lichen sclerosus. Indian J Dermatol. 2015;60:111–7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Bingham JS. Carcinoma of the penis developed in lichen sclerosus et atrophicus. Br J Vener Dis. 1978;54:350–1.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Weigand DA. Lichen sclerosus et atrophicus, multiple dysplastic keratoses and squamous-cell carcinoma of the glans penis. J Dermatol Surg Oncol. 1980;6:45–50.

    Article  CAS  PubMed  Google Scholar 

  38. Barbagli G, Palminteri E, Mirri F, Guazzoni G, Turini D, Lazzeri M. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol. 2006;175(4):1359–63.

    Article  CAS  PubMed  Google Scholar 

  39. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. 1999;41:911–4.

    Article  CAS  PubMed  Google Scholar 

  40. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86:459–65.

    Article  CAS  PubMed  Google Scholar 

  41. Pietrzak P, Hadway P, Corbishley CM, Watkin NA. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int. 2006;98(1):74–6.

    Article  PubMed  Google Scholar 

  42. Powell J, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777–83.

    Article  CAS  PubMed  Google Scholar 

  43. Perceau G, Derancourt C, Clavel C, et al. Lichen sclerosus is frequently present in penile squamous cell carcinomas but is not always associated with oncogenic human papillomavirus. Br J Dermatol. 2003;148(5):934–8.

    Article  CAS  PubMed  Google Scholar 

  44. Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev. 1995;4(6):491–5.

    Article  CAS  PubMed  Google Scholar 

  45. Scurry J. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer. 1999;9:89–97.

    Article  PubMed  Google Scholar 

  46. Algaba F, Horenblas S, Pizzocaro G, Solsona E, Windahl T. European Association of Urology. EAU guidelines on penile cancer. Eur Urol. 2002;42:199–203.

    Article  CAS  PubMed  Google Scholar 

  47. Bunker CB. Male genital skin disease. London: Elsevier Saunders; 2004.

    Google Scholar 

  48. Lowe FC, McCullough AR. Cutaneous horns of the penis: an approach to management. J Am Acad Dermatol. 1985;13:369–73.

    Article  CAS  PubMed  Google Scholar 

  49. Hemandez-Graulau JM, Fiore A, Cea P, et al. Multiple penile horns: case report and review. J Urol. 1988;139:1055–6.

    Article  Google Scholar 

  50. Solivan GA, Smith KJ, James WD. Cutaneous horn of the penis: its association with squamous cell carcinoma and HPV-16 infection. J Am Acad Dermatol. 1990;23:969–72.

    Article  CAS  PubMed  Google Scholar 

  51. Yeager JK, Findlay RF, Mcaleer IM. Penile verrucous carcinoma. Arch Dermatol. 1990;126(9):1208–10.

    Article  CAS  PubMed  Google Scholar 

  52. Mikhail GR. Cancers, precancers, and pseudocancers in the male genitalia. a review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6:1027–35.

    Article  CAS  PubMed  Google Scholar 

  53. Schellhammer PF, Jordan GH, Robey EL, et al. Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. Urol Clin North Am. 1992;19:131–42.

    CAS  PubMed  Google Scholar 

  54. Lever WF, Schaumburg-Lever G. Histopathology of the skin. 5th ed. Philadelphia: JB Lippincott; 1990.

    Google Scholar 

  55. Bunker CB, Francis N. Pseudoeptheliomatous and keratotic micaceous balanitis: comment. Clin Exp Dermatol. 2012;37:434–5.

    Article  CAS  PubMed  Google Scholar 

  56. Bashir SJ, Grant JW, Burrows NP. Pseudoepitheliomatous, keratotic and micaceous balanitis after penile squamous cell carcinoma. Clin Exp Dermatol. 2010;35(7):749–51.

    Article  CAS  PubMed  Google Scholar 

  57. Gray MR, Ansell ID. Pseudo-epitheliomatous hyperkeratotic and micaceous balanitis: evidence for regarding it as pre-malignant. Br J Urol. 1990;66(1):103–4.

    Article  CAS  PubMed  Google Scholar 

  58. Beljaards RC, van Dijk E, Hausman R. Is pseudoepitheliomatous micaceous and keratotic balanitis synonymous with verrucous carcinoma? Br J Dermatol. 1987;117:641–6.

    Article  CAS  PubMed  Google Scholar 

  59. Bart RS, Kopf AW. On a dilemma of penile horns: pseudoepitheliomatous, hyperkeratotic and micaceous balanitis? J Dermatol Surg Oncol. 1977;3(6):580–2.

    Article  CAS  PubMed  Google Scholar 

  60. Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94(9):1253–7.

    Article  PubMed  Google Scholar 

  61. Goette DK, Elgart M, DeVillez RL. Erythroplasia of Queyrat treatment with topically applied 5-Fluorouracil. JAMA. 1975;232(9):934–7.

    Article  CAS  PubMed  Google Scholar 

  62. Micali G, Nasca MR, Tedeschi A. Topical treatment of intraepithelial penile carcinoma with imiquimod. Clin Exp Dermatol. 2003;28 Suppl 1:4–6.

    Article  PubMed  Google Scholar 

  63. Slade HB, Owens ML, Tomai MA, Miller RL. Imiquimod 5 % cream (Aldara). Expert Opin Investig Drugs. 1998;7:437–49.

    Article  CAS  PubMed  Google Scholar 

  64. Suzuki H, Wang B, Shivji GM, et al. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol. 2000;114:135–41.

    Article  CAS  PubMed  Google Scholar 

  65. Tausch TJ, Peterson AC. Early aggressive treatment of lichen sclerosus may prevent disease progression. J Urol. 2012;187:2101–5.

    Article  PubMed  Google Scholar 

  66. Neill SM, Lewis FM, Tatnall FM, Cox NH. British Association of Dermatologists’ guidelines for the management of lichen sclerosus. Br J Dermatol. 2010;163:672–82.

    Article  CAS  PubMed  Google Scholar 

  67. Bunker CB. Comments on the BAD guidelines for the management of lichen sclerosus. Br J Dermatol. 2011;164:894–5.

    Article  CAS  PubMed  Google Scholar 

  68. Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology. 1998;52:559–65.

    Article  CAS  PubMed  Google Scholar 

  69. van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol. 2001;166(5):1670–1.

    Article  PubMed  Google Scholar 

  70. Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after longterm follow up. J Urol. 2003;169(6):2118–21.

    Article  PubMed  Google Scholar 

  71. Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Longterm follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759–62.

    Article  PubMed  Google Scholar 

  72. Hansen JP, Drake AL, Walling HW. Bowen’s Disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg. 2008;34(7):878–83.

    CAS  PubMed  Google Scholar 

  73. Paoli J, Ternesten Bratel A, Löwhagen GB, Stenquist B, Forslund O, Wennberg AM. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm Venereol. 2006;86(5):418–21.

    Article  PubMed  Google Scholar 

  74. Hegarty PK, Shabbir M, Hughes B, et al. Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol. 2009;27:179–87.

    Article  PubMed  Google Scholar 

  75. Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532–6.

    Article  PubMed  Google Scholar 

  76. Shabbir M, Muneer A, Kalsi J, Shukla CJ, Zacharakis E, Garaffa G, Ralph D, Minhas S. Glans resurfacing for the treatment of carcinoma in situ of the penis, surgical technique and outcomes. Eur Urol. 2011;59(1):142–7.

    Article  PubMed  Google Scholar 

  77. Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am. 1992;19(2):291–304.

    CAS  PubMed  Google Scholar 

  78. Shindel AW, Mann MW, Lev RY, et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J Urol. 2007;178(5):1980–5.

    Article  PubMed  Google Scholar 

  79. Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asif Muneer BSC(Hons), MB, MD, FRCS(Urol) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London Limited

About this chapter

Cite this chapter

Shabbir, M., Bunker, C., Muneer, A. (2016). Premalignant Lesions of the Penis. In: Muneer, A., Horenblas, S. (eds) Textbook of Penile Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-33220-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33220-8_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33218-5

  • Online ISBN: 978-3-319-33220-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics